This inventor holds 1 USPTO granted patent. Top assignee: Tel Aviv University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Pnina Gottfried Komlosh: Innovator in Cancer Research
Introduction
Pnina Gottfried Komlosh is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of cancer research, particularly in understanding and modulating the mechanisms of tumor metastasis. Her work focuses on innovative approaches to combat cancer progression and improve therapeutic outcomes.
Latest Patents
Pnina Gottfried Komlosh holds a patent titled "Modulators of human KAI1 metastasis suppressor gene, methods and uses thereof." This invention provides modulators of human cancer and tumor metastasis, specifically targeting SKAI1BC, an antisense long non-coding RNA. This RNA has been identified as an epigenetic suppressor of the metastasis suppressor gene KAI1/CD82. The patent outlines compositions, methods, and uses for decreasing metastasis, invasion, and potentially the proliferation of cancer cells.
Career Highlights
Pnina is affiliated with Tel Aviv University, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential impact on cancer treatment strategies. She is dedicated to advancing the understanding of cancer biology and developing innovative solutions to combat this disease.
Collaborations
Pnina has collaborated with notable colleagues in her field, including Dan Canaani and Ronni Aram. These partnerships have enriched her research and expanded the scope of her work in cancer metastasis.
Conclusion
Pnina Gottfried Komlosh is a trailblazer in cancer research, with a focus on innovative solutions to combat tumor metastasis. Her contributions through her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
